<SEC-DOCUMENT>0001140361-22-033478.txt : 20220915
<SEC-HEADER>0001140361-22-033478.hdr.sgml : 20220915
<ACCEPTANCE-DATETIME>20220915163032
ACCESSION NUMBER:		0001140361-22-033478
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20220909
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220915
DATE AS OF CHANGE:		20220915

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brooklyn ImmunoTherapeutics, Inc.
		CENTRAL INDEX KEY:			0000748592
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				311103425
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		221246073

	BUSINESS ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220
		BUSINESS PHONE:		(212) 582-1199

	MAIL ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN BUZZTIME INC
		DATE OF NAME CHANGE:	20051230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALROY INDUSTRIES INC
		DATE OF NAME CHANGE:	19850411
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc10041894_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:btx="http://brooklynitx.com/20220909" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_29a5f4cf631a469b86f39c6e75164a3a" contextRef="c20220909to20220909" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_eb737f3211d849388e3bb1ba31587f29" contextRef="c20220909to20220909">0000748592</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="btx-20220909.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220909to20220909"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-09</xbrli:startDate><xbrli:endDate>2022-09-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_d71f0f37c6b1410f833152ae5e204588" contextRef="c20220909to20220909">8-K</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_c87e6e9bd31d476fb11c0f55ab9a9ec2" contextRef="c20220909to20220909" format="ixt:datemonthdayyearen">September 9, 2022</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_2dc5deb2d2c6446a908bd257be191524" contextRef="c20220909to20220909">Brooklyn ImmunoTherapeutics, Inc.</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">(Exact Name of Registrant as Specified in its Charter)</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32.61%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_99953898f52c4f79a3e3bf24b6efd2c8" contextRef="c20220909to20220909" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33.68%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_187b939d0c704e32a3898e5bd945aef8" contextRef="c20220909to20220909">001-11460</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_ffa31b474846413d8ceb865709f7c113" contextRef="c20220909to20220909">31-1103425</ix:nonNumeric></div>
            </td>

  </tr>

  <tr>

    <td style="width: 32.61%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(State or Other Jurisdiction of Incorporation)</div>
            </td>

    <td style="width: 33.68%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(Commission File Number)</div>
            </td>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div> <br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.01%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_c58ee14cf01e47719591447fafee2a79" contextRef="c20220909to20220909">10355 Science Center Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_29933d94329b4aee84c41376ab6edb4b" contextRef="c20220909to20220909">Suite 150</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 49.01%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_87d495fdd52b484a8d5b76485f4675a5" contextRef="c20220909to20220909">San Diego</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_202ca236d4a346879f71ba25fde7186d" contextRef="c20220909to20220909" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_88301e01caed4b1b84b9bb3c8b7d3478" contextRef="c20220909to20220909">92121</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.01%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(Address of Principal Executive Offices)</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code: <span style="font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_a88433319a9c49ee8e87ef09d6f187d3" contextRef="c20220909to20220909">212</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_8876cb1d0add4952a4397ed9c925b50d" contextRef="c20220909to20220909">582-1199</ix:nonNumeric></span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
        provisions:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_95726d50e88540dbbcfa8e8fb98463cf" contextRef="c20220909to20220909" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_227ea7ea3408433f8ee5da1eb89e7789" contextRef="c20220909to20220909" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_84d0d50c47564a879b4fe5829507fe46" contextRef="c20220909to20220909" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_888502d2d1cc490ca24f68c2ac3f1048" contextRef="c20220909to20220909" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">Title of each class</div>
            </td>

    <td style="width: 1%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">Trading symbol</div>
            </td>

    <td style="width: 1%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 38%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_7c490bbfe27a4ab9adfe3e16e0ee6454" contextRef="c20220909to20220909">Common Stock, par value $0.005 per share</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 1%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_c10856116cec4162ab7e967d0dc7ccd3" contextRef="c20220909to20220909">BTX</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 1%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_a4ebd1c949374ae4b6031cbe15a896f2" contextRef="c20220909to20220909" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric><br />
              </div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities
        Exchange Act of 1934:</div>

      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_0e958fb2abd34084b0c5e8775894525a" contextRef="c20220909to20220909" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
        financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 1.01</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Entry into a Material Definitive Agreement.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; <br />
      </div>

      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">On September 9, 2022, Brooklyn ImmunoTherapeutics, Inc., a Delaware corporation (the &#8220;<span style="text-decoration: underline;">Company</span>&#8221;), entered into a Master
          Services Agreement with Factor Bioscience Inc., a Delaware corporation (&#8220;<span style="text-decoration: underline;">Factor</span>&#8221;), pursuant to which Factor has agreed to provide services to the Company as agreed between the Company and Factor and set forth in one or more work orders
          under such agreement (including the first work order thereunder, the &#8220;<span style="text-decoration: underline;">MSA</span>&#8221;).&#160; Under the MSA, Factor has agreed to provide the Company with mRNA cell engineering research support services, including access to certain facilities, equipment,
          materials and training, and the Company has agreed to pay Factor an initial fee of $5,000,000, payable in twelve equal monthly installments of $416,667.&#160; Following the initial 12-month period, the Company has agreed to pay Factor a monthly fee of
          $416,667 until such time as the first work order under the MSA is terminated.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">&#160; <br />
        </div>

        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The Company may terminate the first work under the MSA on or after the second anniversary of the date of the MSA, subject to
          providing Factor with 120 days&#8217; prior notice.&#160; Factor may terminate such work order only on and after the fourth anniversary of the date of the MSA, subject to providing the Company with 120 days&#8217; prior notice.&#160; The MSA contains customary
          confidentiality provisions and representations and warranties of the parties, and the MSA may be terminated by ether party upon 30 days&#8217; prior notice, subject to any superseding termination provisions contained in a particular work order.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">&#160; <br />
        </div>

        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">In connection with entering into the MSA, Factor&#8217;s subsidiary, Factor Bioscience Limited (&#8220;<span style="text-decoration: underline;">Factor Limited</span>&#8221;), agreed to
          waive payment of $3,500,000 otherwise payable to it in October 2022 by the Company&#8217;s subsidiaries under the Company&#8217;s previously disclosed Exclusive License Agreement, dated April 26, 2021, by and among Factor Limited and the Company&#8217;s wholly
          owned subsidiaries, Novellus Therapeutics Limited and Brooklyn ImmunoTherapeutics LLC.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">&#160;</div>

      </div>

      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;">The foregoing description of the MSA is only a summary and is qualified in its entirety by reference to the full text of the
          MSA, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference in this Item 1.01.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(d)</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-style: italic; font-weight: bold;">Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160; <br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 9%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div>
              </div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 90%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div>
                <div style="text-align: center; font-weight: bold;"> <br />
                </div>
                <div style="text-align: center; font-weight: bold;">Description</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><a href="brhc10041894_ex10-1.htm">10.1</a></div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify; color: rgb(0, 0, 0);">Master Services Agreement, dated September 9, 2022, by and between Factor Bioscience Inc. and Brooklyn ImmunoTherapeutics, Inc.</div>
            </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 9%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td rowspan="1" colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">104</div>
            </td>

    <td colspan="1" style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
        <div style="page-break-after:always;" class="DSPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto
        duly authorized.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.71%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; font-variant: small-caps;">Brooklyn ImmunoTherapeutics, Inc.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.71%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 49.71%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left;">Dated: September 15<span style="color: rgb(0, 0, 0);">, 2022</span></div>
            </td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left;">By:</div>
            </td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left;">/s/ Andrew Jackson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.71%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Chief Financial Officer</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    </div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>brhc10041894_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%- % - %-->
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.1</font><br>
    </div>
    <div style="text-align: left;"><br>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><u>MASTER SERVICES AGREEMENT</u></div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS MASTER SERVICE AGREEMENT (this &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Agreement</u></font>&#8221;)
          is entered into as of this 9th day of September 2022 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Effective Date</u></font>&#8221;), by and between FACTOR BIOSCIENCE INC., a company organized and existing
          under the laws of the State of Delaware (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Factor</u></font>&#8221;), and BROOKLYN IMMUNOTHERAPEUTICS, INC., a company organized and existing under the laws of the
          State of Delaware (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>BTX</u></font>&#8221;). Factor and BTX may each be referred to in this Agreement individually as a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Party</u></font>&#8221; and collectively as the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Parties</u></font>&#8221;.</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, Factor&#8217;s subsidiary, Factor Bioscience Limited, a company organized and existing under the laws of Ireland, and BTX&#8217;s subsidiary,
          Brooklyn Immunotherapeutics LLC, a limited liability company organized and existing under the laws of the State of Delaware, are parties to that certain Exclusive License Agreement, dated and effective as of April 26, 2021 (hereinafter, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>License</u></font>&#8221;), pursuant to which Factor Bioscience Limited licensed certain technology to Brooklyn Immunotherapeutics LLC in the Field (as such term is
          defined in the License);</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, in support of Brooklyn Immunotherapeutics LLC&#8217;s obligations set forth in the License to develop Licensed Products (as such term is
          defined in the License), BTX desires to engage Factor to perform certain services; and</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, Factor agrees to perform such services in accordance with this Agreement;</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration of the mutual covenants contained in this Agreement, and other good and valuable consideration, the receipt and
          sufficiency of which are hereby acknowledged, the Parties agree as follows:</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Section 1.</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Services</u></font>.</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Services</u></font>.<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>Factor shall perform the services requested by BTX, as mutually agreed upon by the Parties and more
            particularly set forth in one or more written work orders (each, a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Work Order</u></font>&#8221;) entered into by the Parties hereunder (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Services</u></font>&#8221;). Factor may contract with third parties to conduct any part or all of the Services, provided that Factor obtains from such third parties
            written obligations at least as restrictive as those set forth in Section 5.</font></div>
        <div><br>
        </div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Work Orders</u></font>. Each Work Order shall be substantially in the form attached hereto as <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exhibit A</u></font>. The Parties will attach
            sequentially numbered Work Orders to this Agreement, and each such Work Order shall be a complete statement of the relevant project terms and shall supplement the terms and conditions of this Agreement solely for the purposes of such Work
            Order. The terms and conditions of this Agreement shall be deemed incorporated by reference in each such Work Order, except that in the event of any contrary or inconsistent terms or conditions appearing in or referred to in any such Work
            Order, the terms of the Work Order shall control with respect to the applicable Work Order to the extent such Work Order specifically identifies the applicable terms of this Agreement it is intending to supersede. The Parties acknowledge that
            purchase orders or other similar related documents may be issued or executed by BTX in connection with the Services, but this Agreement and any applicable Work Order shall take precedence over any additional, contrary or inconsistent terms and
            conditions appearing or referred to in any such purchase orders or other similar related documents.</font></div>
      </div>
      <div><br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 1 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; text-align: right;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Confidential</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Additional Services and/or Deliverables Not Within the Scope of Work Order No. 1</u></font>.&#160; The Parties acknowledge and agree that in the event that any additional Services or Deliverables will be provided that are
            not expressly identified in Work Order No. 1, including, without limitation, any research or development services, creation of any Deliverables or creation of any Intellectual Property (as defined in the License), it shall be subject to the
            Parties first agreeing to mutually acceptable additional terms to be set forth in the applicable Work Order or an amendment to this Agreement, including, without limitation, representations and warranties, indemnification, ownership and/or
            licensing of Intellectual Property related thereto, which the Parties shall determine through reasonable negotiations conducted in good faith.</font></div>
      </div>
      <div><br>
      </div>
      <div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Non-Exclusivity and Confidentiality</u></font>. It is understood and agreed by and between Factor and BTX that Factor maintains the right to perform similar services on behalf of itself or third parties during the term
            of this Agreement, so long as the confidentiality of information proprietary to BTX is at all times protected by Factor in accordance with Section 5.</font></div>
      </div>
      <div><br>
      </div>
      <div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.5</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Factor Workplace Rules</u></font>. In the event that Factor makes its premises available to BTX or its personnel in connection with the Services performed hereunder, BTX shall, and shall cause its personnel to, comply
            with and to perform its obligations in accordance with Factor&#8217;s applicable instructions, rules, regulations and policies governing conduct in the workplace, as may be updated by Factor from time to time (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Workplace Rules</u></font>&#8221;). Factor may immediately remove any BTX personnel from Factor&#8217;s premises or suspend their access to such premises for noncompliance with the Workplace Rules.
            Factor will promptly notify BTX after the removal or suspension of such personnel, as reasonably appropriate under the circumstances. The Parties will mutually determine in good faith how to resolve the non-compliance in the time frame needed
            by the Parties to avoid any material interruption to the Services. BTX agrees that any BTX personnel on, or equipment or personal property brought onto, Factor&#8217;s premises is at BTX&#8217;s sole risk and Factor is not responsible for any loss or
            damage thereto.</font></div>
      </div>
      <div style="padding-left: 3pt;">
        <div><br>
        </div>
      </div>
      <div style="padding-left: 3pt;">
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Section 2.</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Performance of Services; Compliance</u></font>.</div>
      </div>
      <div style="padding-left: 3pt;">
        <div><br>
        </div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.1</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>General Performance</u></font>. Factor shall perform the Services in material compliance with all applicable laws and regulations, including, without limitation, laws and regulations relating to health, safety and the
            environment, fair labor practices and unlawful discrimination.&#160; In the event that any noncompliance with applicable laws or regulations occurs, Factor shall take such actions as necessary to eliminate such noncompliance to the extent and as
            soon as practicable.</font></div>
        <div><br>
        </div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Animal Welfare</u></font>. With respect to Services involving the use of animals: (a) all such Services will be conducted under Factor&#8217;s supervision and control (whether directly by Factor or by one or more third
            parties hired by Factor pursuant to Section 1.1); (b) all such animals will be cared for, used, and disposed of in conformity with the applicable legal and ethical standards of animal testing; (c) the relevant environment, housing, management,
            veterinary care, and physical plant used in connection with such animals in the Services are appropriate for the nature of the Services; (d) in no circumstances will any such animals be used as food for humans or animals; and (e) if specific
            instructions for animal use, care, handling, or disposal are mutually agreed upon by the Parties in the applicable Work Order, Factor will comply with such instructions in connection with the applicable Services.</font></div>
        <div><br>
        </div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.3</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>FDA Debarment</u></font>. Each Party represents and warrants that neither it nor any of its employees or consultants performing hereunder have been debarred under Section 306(a) or (b) of the U.S. Federal Food, Drug
            and Cosmetic Act. If at any time after the Effective Date a Party becomes aware that it or any of its employees or consultants have been debarred or is in the process of being debarred, such Party shall promptly notify the other Party thereof
            in writing and, in any event, within three (3) business days.</font></div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
          </font></div>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 2 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; text-align: right;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Confidential</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Section 3.</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Term</u></font>.</div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Term</u></font>. This Agreement shall become effective on the Effective Date and shall continue in effect until terminated by either Party in accordance with Section 7. Notwithstanding the foregoing, should any Work
          Order(s) entered into during the term of this Agreement require Services to be performed beyond the termination date of this Agreement, then the terms of this Agreement shall remain in effect with respect to such Work Order(s) until the
          expiration or termination of that Work Order(s).</font></div>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Section 4.</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Payment</u></font>.</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <div style="padding-left: 3pt;">
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Payment Terms</u></font>. In consideration of the Services performed hereunder, BTX will make payments to Factor in accordance with the applicable Work Order. Unless otherwise specified in any Work Order, BTX shall
            make all such payments within thirty (30) days of receipt of an invoice for the same. If a portion of any invoice submitted by Factor hereunder is disputed in good faith by BTX, then BTX shall provide Factor with prompt notice thereof, pay the
            undisputed amounts as set forth in the immediately preceding sentence, and the Parties shall use their good faith efforts to reconcile any disputed amount within thirty (30) days of the date of BTX&#8217;s receipt of such invoice, following which BTX
            shall promptly remit such reconciled amount, if any, to Factor. Late payments are subject to an interest charge of one and one-half percent (1.5%) per month on the outstanding balance. In addition to all other remedies available under this
            Agreement or at law (which Factor does not waive by the exercise of any rights hereunder), Factor shall be entitled to suspend the performance of any Services if BTX fails to pay any amounts/fees when due hereunder.</font></div>
        <div><br>
        </div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Taxes</u></font>. It is expressly understood and agreed that BTX will pay any and all applicable taxes levied or based upon the Services performed under each Work Order (other than Factor&#8217;s income taxes and employment
            related taxes applicable to Factor employees). Any such taxes will appear as a separate item on Factor&#8217;s invoices.</font></div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
          </font></div>
      </div>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Section 5.</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Confidentiality</u></font>.</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>General</u></font>. As used herein, the term &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Confidential Information</u></font>&#8221; means all information furnished by one Party (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Disclosing Party</u></font>&#8221;) to the other Party (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Receiving Party</u></font>&#8221;)




          that is confidential or proprietary to the Disclosing Party (whether or not reduced to writing or other tangible medium of expression, and whether or not patented, patentable, capable of trade secret protection or protected as an unpublished or
          published work under the United States Copyright Act of 1976, as amended), including without limitation, (a) information relating to the intellectual property and business practices of the Disclosing Party; (b) information observed or otherwise
          made available to BTX or its personnel while on Factor&#8217;s premises; and (c) any third party confidential or proprietary information in the possession of the Disclosing Party that is provided to the Receiving Party. Each Party, in its capacity as a
          Receiving Party, agrees to treat as the confidential and exclusive property of the Disclosing Party all Confidential Information that is disclosed or otherwise made available by the Disclosing Party in connection with this Agreement or the
          Parties&#8217; business relationship. The Receiving Party agrees to use any Confidential Information of the other Party solely for purposes of its performance under this Agreement unless otherwise mutually agreed in writing. The Receiving Party shall
          maintain at least the same degree of care and diligence in the protection of the Confidential Information as it uses with regard to its own confidential or proprietary information, which in any event shall be no less than a reasonable standard of
          care and diligence for the industry.</font></div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
        </font></div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 3 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; text-align: right;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Confidential</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Non-Disclosure</u></font>. The Receiving Party agrees not to disclose any Confidential Information of the Disclosing Party to any third party for any purpose without obtaining the prior written consent of the Disclosing
          Party, except to its employees and personnel who have a need to know in order to perform its obligations under this Agreement; provided that such employees and personnel are obligated in writing to maintain the confidential nature of such
          Confidential Information on terms at least as restrictive as those set forth herein, and the Receiving Party will be responsible for any damages resulting from any breach of this Agreement by its employees and personnel.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.3</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Exclusions</u></font>. Confidential Information does not include information that the Receiving Party is able to demonstrate <font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">(a) was
            rightfully in its possession prior to receipt from the Disclosing Party, as evidenced by the Receiving Party&#8217;s written records, (b) is now, or hereafter becomes, part of the public domain through no act or failure to act on the part of the
            Receiving Party or its agents or collaborators, (c) becomes known to the Receiving Party at any time through disclosure by a third party having no known obligation of confidentiality with respect to such information, or (d) was independently
            developed by or on behalf of the Receiving Party without the aid, application, use or benefit of the Disclosing Party&#8217;s Confidential Information, as evidenced by the Receiving Party&#8217;s written records. In addition, a Receiving Party may disclose
            such Confidential Information to the limited extent required to do so by applicable law or a proper legal, governmental or other competent authority, or by the rules of any securities exchange on which any security issued by either Party is
            traded. Except where impracticable, such Receiving Party shall give the Disclosing Party reasonable advance notice of such disclosure requirement and shall afford the Disclosing Party a reasonable opportunity to oppose, limit or secure
            confidential treatment for such required disclosure, or, where it is impracticable to give an advance notice, such Receiving Party shall give the Disclosing Party reasonable notice promptly after such required disclosure. In the event of any
            such required disclosure, the Receiving Party shall disclose only that portion of the Confidential Information legally required to be disclosed.</font></font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Return of Confidential Information</u></font>. Each Party agrees that, upon the earlier to occur of (a) the other Party&#8217;s written request or (b) termination of this Agreement, the Receiving Party shall (i) return to the
          Disclosing Party any or all parts of the Confidential Information of such party provided to the Receiving Party in documentary or other tangible form, including all copies and other tangible embodiments thereof, and (ii) destroy any or all
          Confidential Information in the Receiving Party&#8217;s possession and stored in then-accessible electronic or other media, in accordance with the Receiving Party&#8217;s own policies and timing for the destruction of its own Confidential Information.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Term of Confidentiality Obligations</u></font>. The provisions of this Section 5 shall remain in effect for five (5) years following the termination of this Agreement, except that with respect to any Confidential
          Information constituting a trade secret as defined under applicable law, the provisions of this Section 5 shall remain in effect for as long as such Confidential Information continues to constitute a trade secret.</font></div>
      <div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Section 6.</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Intellectual Property</u></font>.</div>
      </div>
      <div>
        <div><br>
        </div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Deliverables</u></font>.&#160; Unless otherwise specified in the applicable Work Order, all deliverables developed as a result of Factor&#8217;s performance of the Services and as set forth in one or more Work Orders
            (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Deliverables</u></font>&#8221;) are and shall be deemed Improvements (as such term is defined in the License).<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>Notwithstanding the foregoing, Deliverables shall expressly exclude any discovery, advancement, development, or creation which is invented, developed, authored, created, or reduced
            to practice by Factor independently of the Services performed hereunder. Except as expressly set forth herein or in the License, no license or similar grant of rights is intended to be created by this Agreement.</font></div>
      </div>
      <div style="padding-left: 3pt;">
        <div><br>
        </div>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 4 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; text-align: right;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Confidential</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="padding-left: 3pt;">
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Section 7.</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><u>Termination.</u></div>
      </div>
      <div style="padding-left: 3pt;">
        <div><br>
        </div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.1</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Termination</u></font>. This Agreement may be terminated by either Party for any reason upon thirty (30) days&#8217; prior written notice to the other Party, provided, however, that any Work Order issued hereunder that has
            not terminated or expired as of the date of the termination of this Agreement shall survive the termination of this Agreement, and the terms of this Agreement shall remain in full force an effect with respect to any such Work Order. Any Work
            Order issued hereunder may be terminated according to the terms set forth in such Work Order.</font></div>
      </div>
      <div style="padding-left: 3pt;">
        <div><br>
        </div>
      </div>
      <div style="padding-left: 3pt;">
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.2</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Survival</u></font>. The provisions of Sections 5 (Confidentiality), 6 (Intellectual Property), 7.2 (Survival), 8 (Relationship of the Parties), 9 (Notices), and 10 (Miscellaneous) shall survive the termination of this
            Agreement.</font></div>
        <div><br>
        </div>
      </div>
      <div style="padding-left: 3pt;">
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Section 8.</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Relationship of the Parties</u></font>.</div>
      </div>
      <div style="padding-left: 3pt;">
        <div><br>
        </div>
      </div>
      <div style="padding-left: 3pt;">
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">8.1</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Independent Contractor</u></font>. Any Services performed by Factor under this Agreement are to be performed by Factor in Factor&#8217;s capacity as an independent contractor. Neither Factor nor its employees, agents or
            representatives are employees of BTX. Factor retains the sole right to hire, discipline, evaluate and terminate its own employees and to set their hours, wages and terms and conditions of employment in accordance with law and Factor&#8217;s
            obligations herein. All income, employment and other similar taxes required to be withheld and/or paid with respect to all Services provided hereunder will be timely paid by Factor directly to the appropriate governmental agency. The employees,
            representatives or agents of Factor are not entitled to and will not receive from BTX in connection with the Services, any benefits normally provided by BTX to its employees.</font></div>
      </div>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Section 9.</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Notices</u></font>.</div>
      <div style="padding-left: 3pt;">
        <div><br>
        </div>
        <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">9.1</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Notices</u></font>. Any notice required to be given pursuant to the provisions of this Agreement will be in writing and will be deemed to have been given at the time when actually received as a consequence of any
            effective method of delivery, including but not limited to hand delivery, transmission by telecopier, facsimile or electronic transmission, including PDF (portable document format), delivery by a professional courier service or delivery by
            first class, certified or registered mail (postage prepaid) addressed to the Party for whom intended at the address below, or at such changed address as the Party will have specified by written notice in accordance with this Section 9;
            provided, however, that any notice of change of address will be effective only upon actual receipt.</font></div>
        <div><br>
        </div>
      </div>
      <div style="padding-left: 3pt;">
        <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">If to Factor:</div>
      </div>
      <div style="padding-left: 3pt;">
        <div style="text-align: left; text-indent: 72pt; margin-left: 33pt; font-family: 'Times New Roman'; font-size: 10pt;">Factor Bioscience Inc.</div>
        <div style="text-align: left; text-indent: 72pt; margin-left: 33pt; font-family: 'Times New Roman'; font-size: 10pt;">Attn: Christopher Rohde, Ph.D.</div>
        <div style="text-align: left; text-indent: 72pt; margin-left: 33pt; font-family: 'Times New Roman'; font-size: 10pt;">1035 Cambridge Street, Suite 17B</div>
        <div style="text-align: left; text-indent: 72pt; margin-left: 33pt; font-family: 'Times New Roman'; font-size: 10pt;">Cambridge, MA 02141.</div>
        <div style="text-align: left; text-indent: 72pt; margin-left: 33pt; font-family: 'Times New Roman'; font-size: 10pt;">chris.rohde@factorbio.com</div>
      </div>
      <div style="padding-left: 3pt;">
        <div><br>
        </div>
        <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">If to BTX:</div>
      </div>
      <div style="padding-left: 3pt;">
        <div style="text-align: left; text-indent: 72pt; margin-left: 33pt; font-family: 'Times New Roman'; font-size: 10pt;">Brooklyn ImmunoTherapeutics, Inc.</div>
        <div style="text-align: left; text-indent: 72pt; margin-left: 33pt; font-family: 'Times New Roman'; font-size: 10pt;">Attn: Andrew Jackson</div>
        <div style="text-align: left; text-indent: 72pt; margin-left: 33pt; font-family: 'Times New Roman'; font-size: 10pt;">10531 4S Commons Dr., Ste. 160-550</div>
        <div style="text-align: left; text-indent: 72pt; margin-left: 33pt; font-family: 'Times New Roman'; font-size: 10pt;">San Diego, CA 92127.</div>
        <div style="text-align: left; text-indent: 72pt; margin-left: 33pt; font-family: 'Times New Roman'; font-size: 10pt;">ajackson@brooklynitx.com.</div>
      </div>
      <div style="padding-left: 3pt;">
        <div><br>
        </div>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 5 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; text-align: right;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Confidential</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="padding-left: 3pt;">
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Section 10.</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Miscellaneous</u></font>.</div>
        <div><br>
        </div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.1</font>&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Entire Agreement; Amendments</u></font>. This Agreement and any Work Orders issued hereunder, together with the License, represents the entire understanding of the parties with respect to the Services that are subject matter hereof
          and (with the exception of the License) shall merge and supersede all prior and contemporaneous agreements or understandings, oral or written, with respect thereto. This Agreement shall not be modified except by a written agreement signed by the
          Parties hereto specifying that it is a modification to the Agreement.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.2</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Waiver</u></font>. The failure of a Party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver or deprive that Party of the right to insist upon strict adherence
          to that term or any other term of this Agreement. Any waiver must be in writing and signed by the Party making the waiver.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.3</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Severability</u></font>.
          The invalidity or unenforceability of any term or provision of this Agreement shall not affect the validity or enforceability of any other term or provision hereof.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.4</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Governing Law and Venue</u></font>. <font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">This Agreement shall be construed under and governed by the laws of the Commonwealth of Massachusetts,
            without regard to the conflict of laws principles thereof. The Parties hereby submit to the exclusive jurisdiction of the federal and/or state courts sitting in Boston, Massachusetts, without restricting any right of appeal.</font></font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">10.5</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Representations, Warranties and Covenants;</u></font><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>&#160;</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Disclaimer</u></font>. Each Party hereto hereby represents, warrants and covenants to the other that (a) it is a corporation duly incorporated, validly existing and in good standing; (b) it has taken all
          necessary actions on its part to authorize the execution, delivery and performance of the obligations undertaken in this Agreement, and no other corporate or regulatory actions (e.g., obtaining permits, licenses or authorizations) are necessary
          with respect thereto; (c) it is not a party to any agreement or understanding, and there is no applicable law or regulation or third party rights, that would prohibit it from entering into and performing this Agreement or that would be violated
          through entering into this Agreement or any Work Order or the provision or use of the Services or Deliverables&#160; (provided that, with respect to Factor&#8217;s representation under this subsection (c) BTX pays the fees, if any, required for any
          additional license that Factor identifies to BTX in writing as being required under Factor&#8217;s existing agreements for equipment or related software to be provided by Factor for use by BTX as part of the Services or Deliverables under a Work
          Order); and (d) when executed and delivered by it, this Agreement will constitute a legal, valid and binding obligation of it, enforceable against it in accordance with this Agreement&#8217;s terms. Factor further represents and warrants that the
          Services shall be performed in a professional manner by competent and properly trained personnel in accordance with Factor&#8217;s training standards and practices, which are reasonably consistent with standards that are generally accepted in the
          industry.&#160; Except as expressly provided in this Agreement, neither Party makes any representations, extend any warranties of any kind, either express or implied, including, without limitation, any implied warranties of merchantability or any
          implied warranties of fitness for a particular purpose or non-infringement, or assumes any responsibilities whatsoever with respect to the Services or the Deliverables, including the use, sale, or other disposition of products or services
          incorporating or made by use of the Services or the Deliverables. Except for a Party&#8217;s breach of Section 5, in no event will either Party, or its directors, officers, employees, affiliates or agents, be liable for any special, incidental,
          consequential or indirect damages of any kind, whether grounded in tort (including negligence), strict liability, contract or otherwise. The Parties acknowledge that the Services could not be made available under the terms provided herein without
          an increase in cost if Factor were required to provide any representations, warranties or guarantees in addition to, or in lieu of, those expressly set forth in this Agreement.</font></div>
      <div><br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 6 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; text-align: right;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Confidential</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;"><u>Mutual Indemnification</u></font>.&#160; Each Party (the &#8220;<font style="font-family: 'Times New Roman'; font-style: italic;"><u>Indemnifying Party</u></font>&#8221;) will indemnify, defend and hold harmless the other Party, its Affiliates and
            their respective directors, officers, employees, consultants, licensors and agents, and their respective successors, and assigns (collectively, the &#8220;<font style="font-family: 'Times New Roman'; font-style: italic;"><u>Indemnified Party</u></font>&#8221;),
            against all third party suits, actions, claims, proceedings, liabilities, demands, damages, losses, or expenses (including legal expenses, investigative expenses, and reasonable attorneys&#8217; fees) resulting from, arising out of, or otherwise
            attributable to the Indemnifying Party&#8217;s breach of its express representations and warranties set forth herein, except to the extent resulting from, arising out of, or otherwise attributable to the Indemnified Party&#8217;s breach of any of its
            express representations, warranties or covenants set forth herein, or any act of gross negligence or intentional misconduct by the Indemnified Party.<font style="font-family: 'Times New Roman';">&#160;</font>As used herein, &#8220;<font style="font-family: 'Times New Roman'; font-style: italic;"><u>Affiliate</u></font>&#8221; means any person or entity directly or indirectly controlling or having the power to control, or controlled by or being under common control with another
            person or entity.&#160; For this purpose, &#8220;control&#8221; means the direct or indirect possession of power to direct or cause the direction of the management or policies of such party, whether through ownership or stock or other securities, by contract or
            otherwise.&#160; Ownership of more than fifty percent (50%) of the beneficial interest of an entity shall be conclusive evidence that control exists.</font></font></div>
      <div><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Indemnified Party will promptly give notice to the Indemnifying Party of any suits, actions, claims, proceedings, liabilities, demands, damages, losses, or
        expenses which might be covered by this Section and the Indemnifying Party will have the right to defend the same, including selection of counsel and control of the proceedings; provided that the Indemnifying Party will not, without the written
        consent of the Indemnified Party, settle or consent to the entry of any judgment with respect to any such third party claim (x) that does not release the Indemnified Party from all liability with respect to such third party claim or (y) which may
        materially adversely affect the Indemnified Party&#8217;s or under which the Indemnified Party would incur any obligation or liability, other than one as to which the Indemnifying Party has an indemnity obligation hereunder. The Indemnified Party agrees
        to reasonably cooperate and aid such defense.&#160;&#160; The Indemnified Party at all times reserves the right to select and retain counsel of its own at its own expense to defend the Indemnified Party&#8217;s interests.</div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.7</font>&#160;&#160;&#160;&#160;&#160;&#160; <u></u><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Force Majeure</u></font>. Failure of either Party to perform its obligations under this Agreement shall not subject such Party to any liability or place such Party in breach of any term or condition of this Agreement to
          the other Party to the extent that such failure is due to causes beyond the reasonable control of the affected Party including, but not limited to, fire, explosion, flood, drought, hurricane, war, terrorism, riot, civil unrest, sabotage,
          vandalism, embargo, epidemic, pandemic or other declared national, state or local health emergency, compliance with any order or regulation of any government entity acting with color of right, or any other cause beyond the reasonable control of
          such non-performing Party and not caused by the negligence, intentional conduct or misconduct of the non-performing Party (such event or cause referred to as &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>force




              majeure</u></font>&#8221;).&#160; The Party unable to perform hereunder due to force majeure shall, as promptly as reasonably practicable, notify the other Party and shall use reasonable efforts to eliminate, cure or overcome the force majeure, keeping
          the other Party informed of its progress, and resume performance of its obligations as soon as reasonably practicable.&#160; If a condition constituting force majeure exists for more than thirty (30) consecutive days, the Parties shall meet and
          discuss in good faith modifications to the Services, timetable for provision and completion of the Services and/or other affected aspects of the Agreement or Work Order.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.8</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Injunctive Relief</u></font>. Each Party agrees that it would be impossible or inadequate to measure and calculate the other Party&#8217;s damages from any breach of the covenants set forth in Section 5 of this Agreement, and
          that a breach of such covenants could cause serious and irreparable injury to such other Party.&#160; Accordingly, each Party shall have available, in addition to any other right or remedy available to it, the right to seek an injunction from a court
          of competent jurisdiction restraining such a breach (or threatened breach) and to specific performance of any such covenant.&#160; Each Party further agrees that no bond or other security shall be required in seeking such equitable relief.</font></div>
      <div><br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 7 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; text-align: right;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Confidential</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.9</font>&#160;&#160;&#160;&#160;&#160; <u></u><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Assignment</u></font>. This Agreement will be binding upon and will inure to the benefit of each Party and each Party&#8217;s respective transferees, successors and assigns, pursuant to the provisions set forth below.&#160; Neither
          Party may transfer or assign this Agreement without the prior written consent of the other Party, except as provided in this Section 10.9. In the event that a third party (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Acquiring Party</u></font>&#8221;) acquires all or substantially all of a Party&#8217;s business, capital stock or assets, or the portion of such Party&#8217;s assets pertaining to this Agreement, whether by sale, merger, change of
          control, operation of law or otherwise (an &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Acquisition</u></font>&#8221;), such Party may assign this Agreement and the Work Orders hereunder to the Acquiring Party
          without the prior written consent of the other Party, provided that the Acquiring Party agrees in writing to assume the assigning Party&#8217;s obligations under this Agreement and the Work Orders hereunder. In such event, the rights granted to the
          Party being acquired under this Agreement shall inure to the benefit of the Acquiring Party. For the avoidance of doubt, in the event of an Acquisition of BTX by an Acquiring Party, the Acquiring Party will be responsible for all payments and
          other obligations set forth in this Agreement, including, but not limited to, all payments set forth herein, and any obligations that matured prior to the Acquisition date. Upon an Acquisition of BTX by an Acquiring Party, payment thereof shall
          remain an ongoing obligation of the Acquiring Party until such amount is paid in full. Any attempted assignment in contravention of this Section 10.9 will be null and void.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.10</font>&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Announcement</u></font>.&#160; As soon as reasonably practicable after entering into this Agreement, the Parties may issue a joint press release announcing their entering into this Agreement, provided that the content of such
          press release shall be determined by mutual agreement of the Parties acting in good faith.&#160; BTX shall also be entitled to disclose this Agreement in its filings with the Securities and Exchange Commission and as otherwise required in order to
          comply with applicable legal requirements and the rules or regulations of any securities exchange on which BTX&#8217;s securities are listed.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';">10.11</font>&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Counterparts</u></font>. This Agreement may be executed by original or facsimile signature in any number of counterparts, each of which need not contain the signature of more than one Party but all such counterparts taken together
          will constitute one and the same agreement.</font></div>
      <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Remainder of page intentionally left blank.</div>
      <div>
        <div><br>
        </div>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 8 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div id="DSPFPageHeader" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 100%; text-align: right;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Confidential</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Parties hereto have duly executed this Agreement as of the Effective Date first written above.</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z6c855c664d56423280e15fa67be26c91" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FACTOR BIOSCIENCE INC.</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">&#160;</td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
            </td>
            <td style="width: 37%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 18pt;">/s/ Chris Rohde</div>
            </td>
            <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Christopher Rohde, PhD</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Chief Technology Officer</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div>
        <div><br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="zf642b7e5e9244fd4a9fed2435ed3edee" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">&#160;</td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
            </td>
            <td style="width: 37%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">/s/ Andrew Jackson</font></div>
            </td>
            <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Andrew Jackson</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Chief Financial Officer</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">- 9 - </font></div>
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: center; text-indent: 18pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Exhibit A</div>
      </div>
      <div><br>
      </div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">[Form of Work Order]</div>
      <div><br>
      </div>
      <div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Work Order No. [&#9679;] is entered into as of this [&#9679;] day of [&#9679;], [&#9679;], by and between FACTOR BIOSCIENCE INC., a company organized and existing under the laws of the
          State of Delaware (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Factor</u></font>&#8221;), and BROOKLYN IMMUNOTHERAPEUTICS, INC., a company organized and existing under the laws of the State of Delaware (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>BTX</u></font>&#8221;), pursuant to the terms and conditions of the Master Services Agreement between the Parties with an effective date of September ___, 2022 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Agreement</u></font>&#8221;), the terms of which are incorporated herein by reference. Capitalized terms not otherwise defined herein have the meanings assigned to them
          in the Agreement.</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PART I: PROJECT INFORMATION</div>
        <div><br>
        </div>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z8d1368bc54e44e86aa7a63a23117ddac" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

              <tr style="vertical-align: top;">
                <td style="width: 36pt;">&#160;</td>
                <td style="vertical-align: top; width: 36pt;">
                  <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">A.</font></div>
                </td>
                <td style="vertical-align: top; width: auto;">
                  <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Project Title</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z05baeaf1fbbe4b0d9ea48a6e6e2868fd" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

            <tr style="vertical-align: top;">
              <td style="width: 36pt;">&#160;</td>
              <td style="vertical-align: top; width: 36pt;">
                <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">B.</font></div>
              </td>
              <td style="vertical-align: top; width: auto;">
                <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Description</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z5deffca60bfb46ea9afe8e742a5d6ada" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

              <tr style="vertical-align: top;">
                <td style="width: 36pt;">&#160;</td>
                <td style="vertical-align: top; width: 36pt;">
                  <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">C.</font></div>
                </td>
                <td style="vertical-align: top; width: auto;">
                  <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Tasks and Deliverables</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PART II: COSTS AND PAYMENT SCHEDULE</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PART III: TERMINATION</div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Parties hereto have duly executed this Work Order as of the date first written above.</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z04f2aed46bed4587b84e05dd6549285b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FACTOR BIOSCIENCE INC.</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">&#160;</td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
            </td>
            <td style="width: 37%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Christopher Rohde, PhD</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Chief Technology Officer</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div>
        <div><br>
        </div>
        <div><br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z46aee3f936044dafb3b0ab11e6effb81" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">&#160;</td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
            </td>
            <td style="width: 37%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Andrew Jackson</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Chief Financial Officer</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Work Order No. 1</div>
      <div><br>
      </div>
      <div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This Work Order No. 1 is entered into as of this 9th day of September, 2022, by and between FACTOR BIOSCIENCE INC., a company organized and existing under the laws
          of the State of Delaware (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Factor</u></font>&#8221;), and BROOKLYN IMMUNOTHERAPEUTICS, INC., a company organized and existing under the laws of the State of Delaware
          (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>BTX</u></font>&#8221;), pursuant to the terms and conditions of the Master Services Agreement between the Parties with an effective date of September 9, 2022 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;"><u>Agreement</u></font>&#8221;), the terms of which are incorporated herein by reference. Capitalized terms not otherwise defined herein have the meanings assigned to them
          in the Agreement.</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PART I: PROJECT INFORMATION</div>
        <div><br>
        </div>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zdbbd51bf787c4daaa3064d8991da7f6a" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

              <tr style="vertical-align: top;">
                <td style="width: 72pt;">&#160;</td>
                <td style="vertical-align: top; width: 36pt;">
                  <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">A.</font></div>
                </td>
                <td style="vertical-align: top; width: auto;">
                  <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Project Title</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div style="text-align: left; text-indent: 72pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 36pt;">mRNA Cell Engineering Research Support Services</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z8fec2135855044419f31b223632527a7" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

            <tr style="vertical-align: top;">
              <td style="width: 72pt;">&#160;</td>
              <td style="vertical-align: top; width: 36pt;">
                <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">B.</font></div>
              </td>
              <td style="vertical-align: top; width: auto;">
                <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Description</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div style="text-align: justify; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Factor shall provide BTX with mRNA cell engineering research support services, including access to facilities, equipment, materials, and
          training, as more specifically described below.</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z899abb07c8e7405f8cd70a2fb0308b99" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">

              <tr style="vertical-align: top;">
                <td style="width: 72pt;">&#160;</td>
                <td style="vertical-align: top; width: 36pt;">
                  <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">C.</font></div>
                </td>
                <td style="vertical-align: top; width: auto;">
                  <div style="text-align: justify;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Tasks and Deliverables</font></div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">Factor shall provide BTX with:</div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="zb3552c4b9cb14cc69292b290f1451b74" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 126pt;">&#160;</td>
              <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">Access to Factor&#8217;s research laboratory facilities located at 1035 Cambridge Street, in Cambridge, Massachusetts.</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="z7ab039094a98492fb2ff481d031b30c8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 126pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">Access to Factor&#8217;s scientific equipment</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="z73be86409c484650a8219377ae4074e2" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 126pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">Training of BTX research staff in mRNA, iPSC, and gene-editing technology</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="z0c2598f3761a492989a1cf6825b8b5a5" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 126pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">Copies of protocols, formulations, and sequences useful for the development of mRNA cell engineering products</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="z05aab31d1c594e0c83102b6a024dae30" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 126pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman'; font-size: 10pt;">In vitro transcription templates, mRNA constructs, and iPS cells useful for the development of mRNA cell engineering products</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Each Party shall be solely responsible for obtaining and maintaining such insurance coverages as it determines to be necessary and appropriate with respect to its
          operations, assets and personnel.&#160; In the event that Factor or BTX identify any material hazard or unsafe condition with respect to the facilities, equipment or materials provided by Factor hereunder, the applicable Party shall provide written
          notice thereof to the other Party upon becoming aware of same and Factor shall undertake commercially reasonable efforts to eliminate such hazard or unsafe condition as soon as reasonably practicable.</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PART II: COSTS AND PAYMENT SCHEDULE</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">BTX shall pay to Factor a total aggregate fixed fee of Five Million Dollars ($5,000,000) for the Services to be provided under this Work Order No. 1, payable in
          equal monthly installments of $416,667 per month, with each installment due and payable on the last day of each month. The first and the last month&#8217;s installments shall be pro-rated based on the number of days during which the Services are
          provided in such months. BTX shall pay to Factor a deposit equal to $416,667 due and payable on the date hereof, which amount shall be applied to the last payments due.</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Beginning on the first anniversary of the date hereof, and until this Work Order No. 1 is terminated, BTX shall pay to Factor a monthly fee of $416,667 per month
          according to the terms set forth above, less amounts due by Factor to BTX in rent payments, if any.</div>
        <div><br>
        </div>
      </div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after:always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Beginning on the first anniversary of the date hereof, with respect to each payment made under this Work Order No. 1, such payment shall be credited against any
          Milestone Payments (as such term is defined in the License), but only to the extent such Milestone Payments are due within twelve (12) months of the date of such payment made under this Work Order No. 1.</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PART III: TERMINATION</div>
        <div><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Neither Party may terminate this Work Order No. 1 until the second anniversary of the date hereof. BTX may terminate this Work Order No. 1 with such termination
          becoming effective on or after the second anniversary of the Effective Date of the Agreement by providing Factor with at least one hundred twenty (120) days&#8217; prior notice. Either Party may terminate this Work Order No. 1 with such termination
          becoming effective on or after the fourth anniversary of the Effective Date of the Agreement by providing the other Party with at least one hundred twenty (120) days&#8217; prior notice. In the event that a Party hereto fails to materially perform its
          obligations hereunder and such material failure continues for more than thirty (30) days after the other Party has delivered written notice of such failure to the nonperforming Party, then, in addition to other available remedies, the other Party
          shall have the right to suspend the performance if its obligations until the nonperforming Party resumes performance of such Party&#8217;s obligations hereunder.</div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Parties hereto have duly executed this Work Order as of the date first written above.</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="ze407e99169334eea96dae1375da7d85d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">FACTOR BIOSCIENCE INC.</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">
              <div style="margin-left: 9pt">&#160;</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
            </td>
            <td style="width: 37%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 18pt;">/s/ Chris Rohde</div>
            </td>
            <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Christopher Rohde, PhD</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Chief Technology Officer</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div>
        <div><br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z6ed29962aecc4c8591a8eccaff85149a" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BROOKLYN IMMUNOTHERAPEUTICS, INC.</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">&#160;</td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
            </td>
            <td style="width: 37%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">/s/ Andrew Jackson</font></div>
            </td>
            <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Andrew Jackson</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 37%; vertical-align: top;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Chief Financial Officer</div>
            </td>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div>
        <div><br>
        </div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>btx-20220909.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<xs:schema targetNamespace="http://brooklynitx.com/20220909" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:btx="http://brooklynitx.com/20220909" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20220909_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="btx-20220909_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://brooklynitx.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>btx-20220909_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>btx-20220909_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://brooklynitx.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="btx-20220909.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://brooklynitx.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139631227808592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 09, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  09,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Brooklyn ImmunoTherapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000748592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-1103425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10355 Science Center Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">582-1199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.005 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BTX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>brhc10041894_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="btx-20220909.xsd" xlink:type="simple"/>
    <context id="c20220909to20220909">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2022-09-09</startDate>
            <endDate>2022-09-09</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20220909to20220909"
      id="Fact_29a5f4cf631a469b86f39c6e75164a3a">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20220909to20220909"
      id="Fact_eb737f3211d849388e3bb1ba31587f29">0000748592</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20220909to20220909"
      id="Fact_d71f0f37c6b1410f833152ae5e204588">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20220909to20220909"
      id="Fact_c87e6e9bd31d476fb11c0f55ab9a9ec2">2022-09-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20220909to20220909"
      id="Fact_2dc5deb2d2c6446a908bd257be191524">Brooklyn ImmunoTherapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220909to20220909"
      id="Fact_99953898f52c4f79a3e3bf24b6efd2c8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20220909to20220909"
      id="Fact_187b939d0c704e32a3898e5bd945aef8">001-11460</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220909to20220909"
      id="Fact_ffa31b474846413d8ceb865709f7c113">31-1103425</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220909to20220909"
      id="Fact_c58ee14cf01e47719591447fafee2a79">10355 Science Center Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20220909to20220909"
      id="Fact_29933d94329b4aee84c41376ab6edb4b">Suite 150</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20220909to20220909"
      id="Fact_87d495fdd52b484a8d5b76485f4675a5">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20220909to20220909"
      id="Fact_202ca236d4a346879f71ba25fde7186d">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220909to20220909"
      id="Fact_88301e01caed4b1b84b9bb3c8b7d3478">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20220909to20220909"
      id="Fact_a88433319a9c49ee8e87ef09d6f187d3">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220909to20220909"
      id="Fact_8876cb1d0add4952a4397ed9c925b50d">582-1199</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20220909to20220909"
      id="Fact_95726d50e88540dbbcfa8e8fb98463cf">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20220909to20220909"
      id="Fact_227ea7ea3408433f8ee5da1eb89e7789">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20220909to20220909"
      id="Fact_84d0d50c47564a879b4fe5829507fe46">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20220909to20220909"
      id="Fact_888502d2d1cc490ca24f68c2ac3f1048">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20220909to20220909"
      id="Fact_7c490bbfe27a4ab9adfe3e16e0ee6454">Common Stock, par value $0.005 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220909to20220909"
      id="Fact_c10856116cec4162ab7e967d0dc7ccd3">BTX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20220909to20220909"
      id="Fact_a4ebd1c949374ae4b6031cbe15a896f2">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220909to20220909"
      id="Fact_0e958fb2abd34084b0c5e8775894525a">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,^#+U4'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #/@R]54$;S..X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>R'%882;-I:.G#@8K;.QF;+4UBQUC:R1]^R5>FS*V!]C1TN]/
MGT"-#E+W$9]C'S"2Q70WNLXGJ<.:G8B"!$CZA$ZE<DKXJ7GHHU,T/>,1@M(?
MZH@@.%^!0U)&D8(96(2%R-K&:*DC*NKC!6_T@@^?L<LPHP$[=.@I0556P-IY
M8CB/70,WP PCC"Y]%] LQ%S]$YL[P"[),=DE-0Q#.=0Y-^U0P=O3[B6O6UB?
M2'F-TZ]D)9T#KMEU\FN]>=QO62NX$ 5_**K[O>"RYE*LWF?7'WXW8=<;>[#_
MV/@JV#;PZR[:+U!+ P04    " #/@R]5F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M ,^#+U7 %D0B<P0  $P1   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9AA<^(V$(;_BL;M=-J9)+8<2" %9@@DU\S=Y;B8]CKM](.P%]#$MEQ9#N'?
M=V6(S:5F33X$VVA?/UJMWY49;)1^SM< AKTF<9H/G;4QV8WKYN$:$I%?J Q2
M_&:I="(,GNJ5FV<:1%0&);'K>]Z5FPB9.J-!>6VF1P-5F%BF,-,L+Y)$Z.TM
MQ&HS=+CS=N%)KM;&7G!'@TRL( #S>S;3>.96*I%,(,VE2IF&Y= 9\YM;OVL#
MRA%_2-CD!\?,3F6AU+,]>8B&CF>)((;06 F!'R\P@3BV2LCQ[U[4J>YI P^/
MW]3OR\GC9!8BAXF*O\G(K(=.SV$1+$41FR>U^0WV$RH!0Q7GY7^VV8WM=!P6
M%KE1R3X8"1*9[C[%ZSX1AP'\2("_#_!+[MV-2LJI,&(TT&K#M!V-:O:@G&H9
MC7 RM:L2&(W?2HPSHZD*"TRR82*-V%UJI-FRAW2WVIBU@6OP)G:H&^X%;W>"
M_A'! +(+YO7/F._Y_O?A+K)5@'X%Z)=ZET?T)NH%-/M[O,B-QB7\IXEHI]!I
M5K!U?9-G(H2A@X6;@WX!9_33#_S*^Y7@NZSX+BGU.H'S;09-<'1X[_PC =&I
M(#JDRA@)HI+B/A:K)@HZ?BGB' B.;L71/2T9,]!2V8**&)9E8UYHI;*,RCIJ
M*Z2KBNV*5-P7][V,@3T6R0)T$Q6MX7G\G//.E4?P7%<\UZ?P/,%*VM+&I#V*
MI#%3M,ZM1LN+MRE[2)(B5?,U:)%!8628G^&C'%X0K+V*M7<*ZP275HL852-X
M91]AVT1+*WGX=]WI=?O4DO8KK/XI6#A)I3.E2\<Z8X'!BF-*LXDJD!>Q5=28
M5UI\>D<0<J_V5^\4QKEX90\1YD\N95B"$D78(GEIB]"[[/A=BO"@ _!3",=1
MA.Z(-;,_8)]P'/N2-J:N11+INET6A!+2$,JR00^?:NR_%''=$CCIZ#3Q?*,:
MB6G)H)!8-+Q+/=F\[@F<=O7W@!-[AA4Y5YOFEDK+!2)E4PDK1<'5O8+39O\>
MKGI>9EJ]2%RP1D):<S*FT.KVP6G7?X\V4[E!O_E+9D<?XA;%OL]]3K'5[8/3
MWE^NX1AWOL=1: $DH4#JOL%IP_^D0LS);*U2JI&UB'1[/II(OT\1U=V!G]0>
M[A+0*YFNV =4,&O,4Y*)M+%)M BV[4=XW2$X[>+?M#0&4LN"W7%OO7DC$BW4
MAN37'<&G[3M0L0REL8GZC$^>EB)NW-32*JT\M?_[M%G/-)R'F![KU;N=+&XF
MT:^_+)?-I=6BUTIVL/6G3?E_9 ]Y7B!9*R MVPI8^[Q/&_-<&MQ-JB7C_L^+
M7U@ 88'UUECQ+4JV/G%/$!@5/I^Q3&CV(N("V(_>A>=U68;3S=="D]AU!_!I
MMYYK$=GR"[;)0C47'RUP._^3 JG]WF_;Y>\2QNY>P[5(5W!T#]PB]#@.IN.O
M34SNP;NQ_9WAL[ >E;,8EJCD75RCL-Z]NN].C,K*U^6%,OCR71ZN06"]V0'X
M_5(I\W9BW\"K'U!&_P%02P,$%     @ SX,O59^@&_"Q @  X@P   T   !X
M;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@;F)JXI$8MD!AL(U"\V%?E5AV!'KQ
M9+ES^NNGLVPG:75EW8>QS:')W3VZNT=W)YFN6W>2_.'(N2.]DKK=T*-SS?LD
M:0]'KEC[SC1<>Z0R5C'G55LG;6,Y*UMP4C)9WMQDB6)"TV*M.W6G7$L.IM-N
M0V]H4JPKH\^6E :#7\H4)X],;NB62;&W8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!I
MGP*\"!JP'.,HH8T%8Q(RA._]N/P9,&FM5X64,\$E#89BW3#GN-5W7AD6#\87
M$!GEW:GQ#&O+3HOE+3T[##\^R=[8DMLYS8).IF(M>05TK*B/\.M,DP#HG%%>
M* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5<D].)3"6T@L-5)](1&,80)"L2_C!9B
M7X2]_:VPI!&/QGWL_&[TH'_OC./WEE>B'_2^FO-CT1=X=-8T\O1!BEHK'O;^
MRPF+-9O\R-%8\>2SP:0<O(%;2AZY=>)P:?EA6;/CO9NFJ:]PSLM_D/.?K7/-
M-;=,7I+VH_\W5_DMC)/Q]%P<T:L#.EL)7(0;^A7N5WGF0/:=D$[H43N*LN3Z
MQ3GUX1W;^PO\*KY?7_**==+M9G!#S_(77HI.Y?.J>ZC+N.HL?X;[:)'-M[#/
M)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1' L#P8 \PG>&%Y_J?]K-#]
M! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,J^AV&V6PQ>J69? 7CX9Q
M P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@\;J!1Y['NXWE 0^L"]CL
M0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^\?Y@IR1-\SR. !9GD*88
M J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ SX,O59>*NQS
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M"Q4&L&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ SX,O50=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #/@R]5
M4$;S..X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " #/@R]5F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ,^#+U7 %D0B<P0
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M2P$"% ,4    " #/@R]5)!Z;HJT   #X 0  &@              @ 'G$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #/@R]599!Y
MDAD!  #/ P  $P              @ ',$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"   6%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc10041894_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://brooklynitx.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc10041894_8k.htm">brhc10041894_8k.htm</File>
    <File>brhc10041894_ex10-1.htm</File>
    <File>btx-20220909.xsd</File>
    <File>btx-20220909_lab.xml</File>
    <File>btx-20220909_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc10041894_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc10041894_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "btx-20220909_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "btx-20220909_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "btx-20220909.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "btx",
   "nsuri": "http://brooklynitx.com/20220909",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10041894_8k.htm",
      "contextRef": "c20220909to20220909",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://brooklynitx.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc10041894_8k.htm",
      "contextRef": "c20220909to20220909",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://brooklynitx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001140361-22-033478-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-033478-xbrl.zip
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MH3X*';%%?2SI'E#)&1>':$C$;1BWI"KJ(C+.DODCD<^BGN5*4"UIL;K\2[G
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MJ^>V\MB68XZO"R&?9MTG+LAT]K:BIR0]MZRQDW;02<P$3/U/<'K2^GS/JY>
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MJHI)2AG5M?=J[D)7L& R,AV#CJ0A882=?19NQ22?1@PF0;,]0D80[))AJ86
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MMK4J(5\E>5!:-G.=Z;RN];!8+BUL^M280^AC$9Q;67C])/<U\Z[G!%<6 +H
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MQU?UL0_^3J79^ZMP:O2^V_/23\5>,7_S='.U$>(>1Q79Y1]02P,$%     @
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MITA_G$0)#[GS5R)?W-G>L!FC#^3P$(Y5?0O49($*%+@/W*6=8H9*)N4(^)U
M9>?#UQSGYT 98OP04!#@RIM+.6G[JPQ*:?CM0<E\1K,<Q?^2M;5]X *:5->
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M7SAK+FAT;5!+ 0(4 Q0    ( ,^#+U60AC/ P#H  ,Q[ 0 7
M  "  8,4  !B<FAC,3 P-#$X.31?97@Q,"TQ+FAT;5!+ 0(4 Q0    ( ,^#
M+U6&%(]?2 ,  #\/   0              "  7A/  !B='@M,C R,C Y,#DN
M>'-D4$L! A0#%     @ SX,O55BR7,I_"   =%@  !0              ( !
M[E(  &)T>"TR,#(R,#DP.5]L86(N>&UL4$L! A0#%     @ SX,O5<,QM)7>
M!0  ]CX  !0              ( !GUL  &)T>"TR,#(R,#DP.5]P<F4N>&UL
64$L%!@     %  4 2 $  *]A      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
